448 related articles for article (PubMed ID: 21293058)
21. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
22. p63 and p73: teammates or adversaries?
Ratovitski E; Trink B; Sidransky D
Cancer Cell; 2006 Jan; 9(1):1-2. PubMed ID: 16413463
[TBL] [Abstract][Full Text] [Related]
23. P53 family: at the crossroads in cancer therapy.
Alsafadi S; Tourpin S; André F; Vassal G; Ahomadegbe JC
Curr Med Chem; 2009; 16(32):4328-44. PubMed ID: 19754415
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
26. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
[TBL] [Abstract][Full Text] [Related]
27. p73-mediated chemosensitivity: a preferential target of oncogenic mutant p53.
Strano S; Blandino G
Cell Cycle; 2003; 2(4):348-9. PubMed ID: 12851488
[No Abstract] [Full Text] [Related]
28. Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73.
Venkatanarayan A; Raulji P; Norton W; Flores ER
Cell Cycle; 2016; 15(2):164-71. PubMed ID: 26652033
[TBL] [Abstract][Full Text] [Related]
29. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.
Liu J; Uematsu H; Tsuchida N; Ikeda MA
Mol Cancer; 2011 Jul; 10():95. PubMed ID: 21801448
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma].
Zhang T; Jia H; Wang J; Shan Y; Luo S; Tang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(20):919-21. PubMed ID: 19119599
[TBL] [Abstract][Full Text] [Related]
31. Functional regulation of p73 and p63: development and cancer.
Melino G; Lu X; Gasco M; Crook T; Knight RA
Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
[TBL] [Abstract][Full Text] [Related]
32. The p53 family: same response, different signals?
Chen X
Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
[TBL] [Abstract][Full Text] [Related]
33. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk among p53 family members in cutaneous carcinoma.
Missero C; Antonini D
Exp Dermatol; 2014 Mar; 23(3):143-6. PubMed ID: 24417641
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915
[TBL] [Abstract][Full Text] [Related]
37. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
38. p63 and p73, the ancestors of p53.
Dötsch V; Bernassola F; Coutandin D; Candi E; Melino G
Cold Spring Harb Perspect Biol; 2010 Sep; 2(9):a004887. PubMed ID: 20484388
[TBL] [Abstract][Full Text] [Related]
39. Regulating the genome surveillance system: miRNAs and the p53 super family.
Bailey SG; Sanchez-Elsner T; Stephanou A; Cragg MS; Townsend PA
Apoptosis; 2010 May; 15(5):541-52. PubMed ID: 20091234
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.
Yao Y; Bellon M; Shelton SN; Nicot C
J Biol Chem; 2012 Jun; 287(24):20737-47. PubMed ID: 22496369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
